Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report) reached a new 52-week high on Thursday . The company traded as high as GBX 1,809.18 ($22.62) and last traded at GBX 1,808.85 ($22.61), with a volume of 850 shares. The stock had previously closed at GBX 1,784.40 ($22.31).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Trading Up 1.4 %
The company has a quick ratio of 9.27, a current ratio of 9.42 and a debt-to-equity ratio of 0.04. The business has a 50-day moving average of GBX 1,695.53 and a two-hundred day moving average of GBX 1,623.23. The firm has a market capitalization of £5.34 billion and a price-to-earnings ratio of -1,644.41.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Further Reading
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- What is the NASDAQ Stock Exchange?
- Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead?
- How to invest in marijuana stocks in 7 steps
- RTX and Lockheed Martin: Buy 1 for Today and 1 for Tomorrow
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3 Must-Have ETFs Set to Dominate This Quarter
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.